Heart pump support for severe heart failure
Part of Heart & circulation clinical trials.
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have severe heart failure or low cardiac output syndrome, which may occur after heart surgery, during a heart failure crisis, or while waiting for a heart transplant.
- Your condition must include signs of poor blood flow (like confusion, cold skin, or low urine output), low blood pressure, and at least one lab or heart measurement showing severe heart strain.
- You must have already tried standard treatments like medicine and an intra-aortic balloon pump (IABP) without success.
- You cannot have conditions like severe infection, cancer, recent stroke, active bleeding, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial tests a new heart pump device (CorVad) to support the heart in people who are in cardiogenic shock after a heart attack. It may help stabilize blood pressure and improve blood flow, potentially giving the heart time to recover.
This trial is testing whether a temporary heart pump (Impella) can help people with severe heart failure and cardiogenic shock (when the heart can't pump enough blood). The goal is to see if this device can reduce fluid buildup and improve blood flow, but it's for people who are very ill and need extra support.
This trial tests a new heart-assist device designed to help patients whose hearts are too weak to pump blood on their own after heart surgery. The device is placed through a catheter (thin tube) and aims to improve blood flow and survival in people who don't respond to standard medications.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.